Harmony Biosciences

HRMYNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.237 B

$38.41 -0.88%

Close of 7 Aug 2026

Revenue

$868.5M

#1606 by revenue

Earnings

$158.7M

#1109 by earnings

Shares outstanding

58,236,393

Latest filing cover page

P/E ratio

14.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#102Palvella TherapeuticsPVLA$2.27B
#103Mineralys TherapeuticsMLYS$2.26B
#104Harmony BiosciencesHRMY$2.24B
#105SELLAS Life Sciences GroupSLS$2.23B
#106BiohavenBHVN$2.21B

Where these numbers come from

Share counts and financials for Harmony Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.